185 related articles for article (PubMed ID: 27418539)
1. Mutations specific to the Rac-GEF domain of
Pengelly RJ; Greville-Heygate S; Schmidt S; Seaby EG; Jabalameli MR; Mehta SG; Parker MJ; Goudie D; Fagotto-Kaufmann C; Mercer C; ; Debant A; Ennis S; Baralle D
J Med Genet; 2016 Nov; 53(11):735-742. PubMed ID: 27418539
[TBL] [Abstract][Full Text] [Related]
2. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
[TBL] [Abstract][Full Text] [Related]
3. More evidence on TRIO missense mutations in the spectrin repeat domain causing severe developmental delay and recognizable facial dysmorphism with macrocephaly.
Kloth K; Graul-Neumann L; Hermann K; Johannsen J; Bierhals T; Kortüm F
Neurogenetics; 2021 Jul; 22(3):221-224. PubMed ID: 34013494
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic TRIO variants associated with neurodevelopmental disorders perturb the molecular regulation of TRIO and axon pathfinding in vivo.
Bonnet M; Roche F; Fagotto-Kaufmann C; Gazdagh G; Truong I; Comunale F; Barbosa S; Bonhomme M; Nafati N; Hunt D; Rodriguez MP; Chaudhry A; Shears D; Madruga M; Vansenne F; Curie A; Kajava AV; Baralle D; Fassier C; Debant A; Schmidt S
Mol Psychiatry; 2023 Apr; 28(4):1527-1544. PubMed ID: 36717740
[TBL] [Abstract][Full Text] [Related]
5. Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome.
Hempel A; Pagnamenta AT; Blyth M; Mansour S; McConnell V; Kou I; Ikegawa S; Tsurusaki Y; Matsumoto N; Lo-Castro A; Plessis G; Albrecht B; Battaglia A; Taylor JC; Howard MF; Keays D; Sohal AS; ; Kühl SJ; Kini U; McNeill A
J Med Genet; 2016 Mar; 53(3):152-62. PubMed ID: 26543203
[TBL] [Abstract][Full Text] [Related]
6. [Role of the multifunctional Trio protein in the control of the Rac1 and RhoA gtpase signaling pathways].
Bellanger JM; Zugasti O; Lazaro JB; Diriong S; Lamb N; Sardet C; Debant A
C R Seances Soc Biol Fil; 1998; 192(2):367-74. PubMed ID: 9759378
[TBL] [Abstract][Full Text] [Related]
7. A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay.
Trinh J; Hüning I; Yüksel Z; Baalmann N; Imhoff S; Klein C; Rolfs A; Gillessen-Kaesbach G; Lohmann K
J Hum Genet; 2018 Sep; 63(9):997-1001. PubMed ID: 29899504
[TBL] [Abstract][Full Text] [Related]
8. RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes.
Reijnders MRF; Ansor NM; Kousi M; Yue WW; Tan PL; Clarkson K; Clayton-Smith J; Corning K; Jones JR; Lam WWK; Mancini GMS; Marcelis C; Mohammed S; Pfundt R; Roifman M; Cohn R; Chitayat D; ; Millard TH; Katsanis N; Brunner HG; Banka S
Am J Hum Genet; 2017 Sep; 101(3):466-477. PubMed ID: 28886345
[TBL] [Abstract][Full Text] [Related]
9. Identification of a mitotic Rac-GEF, Trio, that counteracts MgcRacGAP function during cytokinesis.
Cannet A; Schmidt S; Delaval B; Debant A
Mol Biol Cell; 2014 Dec; 25(25):4063-71. PubMed ID: 25355950
[TBL] [Abstract][Full Text] [Related]
10. Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms.
Stevens SJ; van Essen AJ; van Ravenswaaij CM; Elias AF; Haven JA; Lelieveld SH; Pfundt R; Nillesen WM; Yntema HG; van Roozendaal K; Stegmann AP; Gilissen C; Brunner HG
Genome Med; 2016 Dec; 8(1):131. PubMed ID: 27964749
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
[TBL] [Abstract][Full Text] [Related]
12. RNA analysis and computer-aided facial phenotyping help to classify a novel TRIO splice site variant.
Schwartzmann S; Zhao M; Sczakiel HL; Hildebrand G; Ehmke N; Horn D; Mensah MA; Boschann F
Am J Med Genet A; 2024 Mar; ():e63599. PubMed ID: 38517182
[TBL] [Abstract][Full Text] [Related]
13. Case report: Phenotype expansion and analysis of
Liu Y; Liang Z; Cai W; Shao Q; Pan Q
Front Neurol; 2022; 13():948877. PubMed ID: 36105777
[TBL] [Abstract][Full Text] [Related]
14. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.
Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A
Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic analyses in syndromic intellectual disability with primary microcephaly reveal biallelic and de novo variants in patients with parental consanguinity.
Mercan S; Akcakaya NH; Salman B; Yapici Z; Ozbek U; Ugur Iseri SA
Genes Genomics; 2023 Jan; 45(1):13-21. PubMed ID: 36371492
[TBL] [Abstract][Full Text] [Related]
16. Novel loss-of-function variants in TRIO are associated with neurodevelopmental disorder: case report.
Schultz-Rogers L; Muthusamy K; Pinto E Vairo F; Klee EW; Lanpher B
BMC Med Genet; 2020 Nov; 21(1):219. PubMed ID: 33167890
[TBL] [Abstract][Full Text] [Related]
17. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
[TBL] [Abstract][Full Text] [Related]
19. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
[TBL] [Abstract][Full Text] [Related]
20. Extending the phenotypes associated with TRIO gene variants in a cohort of 25 patients and review of the literature.
Gazdagh G; Hunt D; Gonzalez AMC; Rodriguez MP; Chaudhry A; Madruga M; Vansenne F; Shears D; Curie A; Stattin EL; Anderlid BM; Trajkova S; Angelovska ES; McWilliam C; Wyatt PR; O'Driscoll M; Atton G; Bergman AK; Zacher P; Mewasingh LD; López AG; Alonso-Luengo O; Wai HA; Rohde O; Boiroux P; Debant A; Schmidt S; Baralle D
Am J Med Genet A; 2023 Jul; 191(7):1722-1740. PubMed ID: 36987741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
